With this blog, we seek to provide news and thoughtful perspectives on the translation of effective health interventions to community practice – the T2 step, from ”bedside to community”.
Here we review news and research in a wide T2 context, offering our reflections on broader implications and tackling questions such as: How do new research findings inform our understanding of T2 programmatic opportunities? In what way does T2 news reflect – or alter – trends in bedside to community translation? What difference does it make to the T2 enterprise if a large translation effort changes practice by 20%? Or 10%? Or not at all? What are the economic implications of failing or succeeding in the T2 mission? To help foster T2 progress, we share best practices, tips and tools with our various intersecting communities of interest. We respect the diversity of views and are looking forward to interesting debates, provided that all communication is respectful.
Join our dialogue and share your thoughts with us!
- James G. Kahn, MD, MPH, Professor of Health Policy & Epidemiology, co-Director Community Engagement & Health Policy Program, UCSF Clinical & Translational Science Institute, University of California, San Francisco. Learn more
- Richard Wang, MPH, Research Associate, Health Policy, UCSF Clinical and Translational Science Institute.
- Ellen Goldstein, MA, Program Manager, Community Engagement Program
- Ralph Gonzales, MD, MSPH, Professor of Medicine; and Epidemiology and Biostatistics and Associate Director, Clinical and Translational Sciences K12 Career Development Program. Learn more